Unlike the commodities stocks (that I think are getting overvalued by this point) the biotech stocks have been absolutely thrashed this past year. But the industry is still fundamentally strong. People need medicines.
Not just that but biotech is largely recession proof. This is not discretionary spending. And much of it is covered by insurance plans and government social spending.
I'm even considering the ARK genomics fund. Talk me out if it. If you can.
Leave a Reply